PMID: 8610645Apr 1, 1996Paper

Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial

American Journal of Clinical Oncology
Ernesto MaranzanoM Tonato

Abstract

A phase II trial was planned to investigate the feasibility of radiotherapy (RT) without steroids in 20 consecutive patients with metastatic spinal cord compression (MSCC), no neurologic deficits, or only radiculopathy, and no massive invasion of the spine at magnetic resonance imaging (MRI) or computed tomography (CT). Aiming at an early diagnosis, MRI or CT was prescribed for all cancer patients with back pain and osteolysis, even when there were no signs of neurologic spinal compression. All patients were given 30 Gy in 10 fractions over 2 weeks with no steroids. Back pain and motor capacity were the parameters adopted to verify response to RT. Sixteen of 20 patients (80%) were able to walk without support, and 14 (70%) had no radiculopathy. Seventeen of 20 cases (85%) achieved relief from back pain. Regarding motor function, all patients (100%) responded to RT because the 16 patients able to walk without support at diagnosis did not deteriorate and the other 4, who needed support, became ambulatory without motor impairment. Median survival time was 14 months. Eight of 20 (40%) treated patients are still alive (14 to 36 months after end of RT), fully ambulatory, and free from relapse in the treated spine. Acute side effects ...Continue Reading

References

Jan 1, 1978·Annals of Neurology·R W GilbertJ B Posner
Aug 27, 1992·The New England Journal of Medicine·T N Byrne
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·T Bates
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·C LandmannO Gratzl
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·E MaranzanoS Ricci
Jul 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P LatiniE Perrucci
Mar 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D E Weissman

❮ Previous
Next ❯

Citations

Oct 31, 2003·Current Treatment Options in Oncology·Madhuri Yalamanchili, Glenn J Lesser
Mar 28, 2008·Current Oncology Reports·Marta Penas-Prado, Monica E Loghin
Jul 15, 1995·International Journal of Radiation Oncology, Biology, Physics·E Maranzano, P Latini
Sep 24, 2002·International Journal of Radiation Oncology, Biology, Physics·C Leland RogersBurton L Speiser
Jul 15, 1997·International Journal of Radiation Oncology, Biology, Physics·E MaranzanoE Corgna
Aug 26, 1999·Seminars in Oncology Nursing·J D Bucholtz
Feb 9, 2006·Neurosurgical Focus·W B Jacobs, R G Perrin
Jan 10, 2013·Current Oncology·S L'espéranceUNKNOWN Comité de l’évolution des pratiques en oncologie
May 26, 2004·Current Treatment Options in Neurology·Robert Cavaliere, David Schiff
Sep 22, 2000·Current Review of Pain·H A Zekry, E Bruera
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Andrew LoblawNormand J Laperriere
Sep 1, 2000·Seminars in Oncology Nursing·P M Barse
Nov 29, 2005·Critical Reviews in Oncology/hematology·Silvia SpinazzéDirk Schrijvers
Jan 1, 2013·Journal of Clinical Medicine·Ripamonti CarlaMaranzano Ernesto
Apr 25, 2017·Clinical Spine Surgery : a Spine Publication·Abhishek KumarCharles G Fisher
Jul 15, 2015·Therapeutic Advances in Urology·Jim N Rose, Juanita M Crook
Sep 3, 2010·Nature Reviews. Clinical Oncology·Dirk Rades, Janet L Abrahm
Oct 11, 2005·Journal of Neuro-oncology·Melike MutMark E Shaffrey
Feb 18, 2004·International Journal of Palliative Nursing·Sarah Heatley
Aug 7, 2008·International Journal of Palliative Nursing·Lawrence Drudge-Coates, Krishnamoorthy Rajbabu
Apr 8, 2020·Indian Journal of Orthopaedics·Vineet KurisunkalSrinath Gupta
Mar 9, 2021·World Neurosurgery·Jose A CansecoAlexander R Vaccaro
Jul 16, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ran Harel, Lilyana Angelov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
M LeviovA Kuten
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
S SørensenH H Hansen
© 2021 Meta ULC. All rights reserved